feedback

Course Director

Anas Younes, MD
Anas Younes, MD

Memorial Sloan Kettering Cancer Center
New York, New York

Faculty

Craig H. Moskowitz
Craig H. Moskowitz, MD

Memorial Sloan Kettering Cancer Center
Weill Medical College
New York, New York

Accredited by

The Medical College of Wisconsin

Activity Details

Credit Types:CME
Credit Amount:1.0 Credits
Release Date:2018-Apr-04
Expiration Date:2019-Apr-03
Estimated Time for Completion:60 Minutes
Registration Required:No
Cost:Free of charge

Activity Description and Educational Objectives

In this activity, experts in the management of Hodgkin lymphoma (HL) discuss progress in integrating novel therapies into treatment protocols that include autologous stem cell transplantation (ASCT) as part of an overall management approach to HL; the experts discuss new evidence on antibody–drug conjugates and immunotherapies as both pre- and post-transplant regimens, as well as practical issues related to the safe and effective use of newer agents in transplant-eligible populations, including the combination of antibody and immune treatments in the HL setting.

Upon completion of this activity, participants should be better able to:
  • Summarize transplant eligibility criteria and evidence on the role of novel therapeutics in conjunction with ASCT in the HL setting
  • Cite updated evidence on the use of novel therapy for HL as induction therapy, post-transplant consolidation, or as post-ASCT options in relapsed disease
  • Integrate novel therapeutics into pre- and post-transplant regimens for patients with HL who are eligible for ASCT

Target Audience

This activity has been designed to meet the educational needs of hematologist-oncologists, oncologists, BMT specialists, BMT nurse specialists, and other clinicians involved in the management of Hodgkin lymphoma.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: April 04, 2018 - April 03, 2019
Time to Complete: 60 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, The Medical College of Wisconsin has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Moderator

Anas Younes, MD
Chief, Lymphoma Service
Memorial Sloan Kettering Cancer Center
New York, New York

Anas Younes, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Bristol-Myers Squibb Company; Curis, Inc.; F. Hoffmann-La Roche Ltd; Johnson & Johnson Inc.; and Novartis Pharmaceuticals Corporation.
Honoraria from Bayer Corporation; Bristol-Myers Squibb Company; Celgene Corporation; Genentech, Inc.; Incyte Corporation; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; sanofi-aventis U.S. LLC; Seattle Genetics, Inc.; and Takeda Pharmaceuticals U.S.A., Inc./Millennium Pharmaceuticals, Inc.

Faculty

Craig H. Moskowitz, MD
Steven A. Greenberg Chair in Lymphoma Research
Clinical Director, Division of Hematologic Oncology
Attending, Lymphoma and Adult Bone Marrow Transplant Services
Member, Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Medical College
New York, New York

Craig H. Moskowitz, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Bristol-Myers Squibb Company; Merck & Co., Inc.; and Seattle Genetics, Inc.

Medical Director

Carmine DeLuca
PVI, PeerView Institute for Medical Education

Carmine DeLuca has no financial interests/relationships or affiliations in relation to this activity.

The Medical College of Wisconsin (MCW) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by MCW for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Providership, Credit & Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Medical College of Wisconsin and PVI, PeerView Institute for Medical Education. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.

The Medical College of Wisconsin designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Providership

This CME activity is jointly provided by The Medical College of Wisconsin and PVI, PeerView Institute for Medical Education.

Support

This activity is supported through educational grants from Bristol-Myers Squibb, Merck & Co., Inc., and Seattle Genetics.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. For approved prescribing information, please consult the manufacturer’s product labeling.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

About This CME Activity

PVI, PeerView Institute for Medical Education, and The Medical College of Wisconsin are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and The Medical College of Wisconsin.

Copyright © 2000-2018, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.